-Bloomberg
Lilly’s Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
Eli Lilly And Co’s (NYSE:LLY) lebrikizumab ADvocate 1 and ADvocate 2 Phase 3 clinical trials met primary and all key…
Related Posts
‘Hawaii Senators Approve Bill To Promote Research Into Psilocybin And MDMA Therapy’ – Marijuana Moment
https://www.marijuanamoment.net/hawaii-senators-approve-bill-to-promote-research-into-psilocybin-and-mdma-therapy/
Hawaii senators have approved a bill in committee to promote research into the therapeutic potential of
Xenon Receives $15M Regulatory Milestone Under Epilepsy Pact With Neurocrine
Xenon Pharmaceuticals Inc's (NASDAQ: XENE) collaboration to develop treatments for epilepsy with Neurocrine Biosciences Inc (NASDAQ: NBIX) achieved a regulatory milestone,
REV Ambulance Group Company Delivers All-Electric, Zero-Emission Ambulance To DocGo
BROOKFIELD, Wis.--(BUSINESS WIRE)-- REV Group, Inc. (NYSE:REVG) which includes companies that manufacture Horton®, AEV®, Road Rescue®, Wheeled Coach® and Leader® brand ambulances, announces the